Cargando…

ENKUR expression induced by chemically synthesized cinobufotalin suppresses malignant activities of hepatocellular carcinoma by modulating β-catenin/c-Jun/MYH9/USP7/c-Myc axis

ENKUR plays a crucial role in lung and colorectal cancers. Chemically synthesized cinobufotalin (CB) showed its significant anti-cancer effect in nasopharyngeal carcinoma. However, the roles of ENKUR and CB along with their correlation are still unknown in hepatocellular carcinoma (HCC). In this stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Rentao, Li, Yonghao, Luo, Xiaojun, Zhang, Wan, Yang, Huiling, Zhang, Yewei, Liu, Jiahao, Liu, Shaohua, Han, Siyuan, Liu, Chen, Huang, Yun, Liu, Zhen, Li, Aimin, Fang, Weiyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990461/ https://www.ncbi.nlm.nih.gov/pubmed/35414777 http://dx.doi.org/10.7150/ijbs.67476

Ejemplares similares

ENKUR recruits FBXW7 to ubiquitinate and degrade MYH9 and further suppress MYH9‐induced deubiquitination of β‐catenin to block gastric cancer metastasis
por: Liu, Jiahao, et al.
Publicado: (2022)

Chemical compound cinobufotalin potently induces FOXO1-stimulated cisplatin sensitivity by antagonizing its binding partner MYH9
por: Li, YongHao, et al.
Publicado: (2019)

MYH10 Combines with MYH9 to Recruit USP45 by Deubiquitinating Snail and Promotes Serous Ovarian Cancer Carcinogenesis, Progression, and Cisplatin Resistance
por: Liu, Longyang, et al.
Publicado: (2023)

Cinobufotalin as an effective adjuvant therapy for advanced gastric cancer: a meta-analysis of randomized controlled trials
por: Sun, Huiling, et al.
Publicado: (2019)

Targeting MYH9 represses USP14-mediated NAP1L1 deubiquitination and cell proliferation in glioma
por: Chen, Zigui, et al.
Publicado: (2023)

Combined Treatment of Cinobufotalin and Gefitinib Exhibits Potent Efficacy against Lung Cancer
por: Han, Youxi, et al.
Publicado: (2021)

VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma
por: Liang, Zixi, et al.
Publicado: (2019)

Network Pharmacology Prediction: The Possible Mechanisms of Cinobufotalin against Osteosarcoma
por: Chen, Riyu, et al.
Publicado: (2022)

The Potential Mechanisms of Cinobufotalin Treating Colon Adenocarcinoma by Network Pharmacology
por: Wang, Jiyan, et al.
Publicado: (2022)

Elucidation of the Differences in Cinobufotalin’s Pharmacokinetics Between Normal and Diethylnitrosamine-Injured Rats: The Role of P-Glycoprotein
por: Zhang, Xiaojing, et al.
Publicado: (2019)

USP38 critically promotes asthmatic pathogenesis by stabilizing JunB protein
por: Chen, Siyuan, et al.
Publicado: (2018)

Deubiquitinase USP18 promotes the progression of pancreatic cancer via enhancing the Notch1-c-Myc axis
por: Feng, Long, et al.
Publicado: (2020)

Selection and Characterization of a DNA Aptamer That Can Discriminate between cJun/cJun and cJun/cFos
por: Walters, Ryan D., et al.
Publicado: (2014)

Network Pharmacology Study on the Pharmacological Mechanism of Cinobufotalin Injection against Lung Cancer
por: Mao, Yun, et al.
Publicado: (2020)

ENKUR Is Involved in the Regulation of Cellular Biology in Colorectal Cancer Cells via PI3K/Akt Signaling Pathway
por: Ma, Qing, et al.
Publicado: (2019)

CCDC65 as a new potential tumor suppressor induced by metformin inhibits activation of AKT1 via ubiquitination of ENO1 in gastric cancer
por: Deng, Tongyuan, et al.
Publicado: (2021)

Investigating In Situ Expression of c-MYC and Candidate Ubiquitin-Specific Proteases in DLBCL and Assessment for Peptidyl Disruptor Molecule against c-MYC-USP37 Complex
por: Kamran, Durr e Sameen, et al.
Publicado: (2023)

Activation of the c-Jun NH(2)-terminal kinase pathway by coronavirus infectious bronchitis virus promotes apoptosis independently of c-Jun
por: Fung, To Sing, et al.
Publicado: (2017)

HMGA1 stimulates MYH9-dependent ubiquitination of GSK-3β via PI3K/Akt/c-Jun signaling to promote malignant progression and chemoresistance in gliomas
por: Que, Tianshi, et al.
Publicado: (2021)

NAP1L1 interacts with hepatoma-derived growth factor to recruit c-Jun inducing breast cancer growth
por: Liu, Shu, et al.
Publicado: (2021)

Oncogenic USP22 supports gastric cancer growth and metastasis by activating c-Myc/NAMPT/SIRT1-dependent FOXO1 and YAP signaling
por: Liu, Hongxia, et al.
Publicado: (2019)

USP16 regulates castration-resistant prostate cancer cell proliferation by deubiquitinating and stablizing c-Myc
por: Ge, Jianchao, et al.
Publicado: (2021)

METTL5 stabilizes c‐Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression
por: Xia, Peng, et al.
Publicado: (2023)

VRK1 promotes cisplatin resistance by up-regulating c-MYC via c-Jun activation and serves as a therapeutic target in esophageal squamous cell carcinoma
por: Liu, Zhen-Chuan, et al.
Publicado: (2017)

ENKUR acts as a tumor suppressor in lung adenocarcinoma cells through PI3K/Akt and MAPK/ERK signaling pathways
por: Ma, Qing, et al.
Publicado: (2019)

SNHG17, as an EMT‐related lncRNA, promotes the expression of c‐Myc by binding to c‐Jun in esophageal squamous cell carcinoma
por: Shen, Supeng, et al.
Publicado: (2021)

Correction to: NAP1L1 interacts with hepatoma-derived growth factor to recruit c-Jun inducing breast cancer growth
por: Liu, Shu, et al.
Publicado: (2022)

Correction to: HMGA1 stimulates MYH9-dependent ubiquitination of GSK-3β via PI3K/Akt/c-Jun signaling to promote malignant progression and chemoresistance in gliomas
por: Que, Tianshi, et al.
Publicado: (2022)

The deubiquitinating enzyme USP37 promotes keloid fibroblasts proliferation and collagen production by regulating the c‐Myc expression
por: Piao, Meishan, et al.
Publicado: (2022)

Phosphoproteomics reveals that cinobufotalin promotes intrahepatic cholangiocarcinoma cell apoptosis by activating the ATM/CHK2/p53 signaling pathway
por: Xia, Zhili, et al.
Publicado: (2022)

Dual roles of miR-374a by modulated c-Jun respectively targets CCND1-inducing PI3K/AKT signal and PTEN-suppressing Wnt/β-catenin signaling in non-small-cell lung cancer
por: Zhao, Mengyang, et al.
Publicado: (2018)

c-Myc-activated USP2-AS1 suppresses senescence and promotes tumor progression via stabilization of E2F1 mRNA
por: Li, Bingyan, et al.
Publicado: (2021)

USP28 deletion and small-molecule inhibition destabilizes c-MYC and elicits regression of squamous cell lung carcinoma
por: Ruiz, E Josue, et al.
Publicado: (2021)

Retraction Note: Dual roles of miR-374a by modulated c-Jun respectively targets CCND1-inducing PI3K/AKT signal and PTEN-suppressing Wnt/β-catenin signaling in non-small-cell lung cancer
por: Zhao, Mengyang, et al.
Publicado: (2021)

The Effectiveness and Safety of Cinobufotalin Injection as an Adjunctive Treatment for Lung Cancer: A Meta-Analysis of Randomized Controlled Trials
por: Li, Lin-Lu, et al.
Publicado: (2021)

PTTG1 is involved in TNF‐α‐related hepatocellular carcinoma via the induction of c‐myc
por: Lin, Xianyi, et al.
Publicado: (2019)

USP47 inhibits m(6)A-dependent c-Myc translation to maintain regulatory T cell metabolic and functional homeostasis
por: Wang, Aiting, et al.
Publicado: (2023)

HTLV-3 and HTLV-4 antisense proteins activate JunB-, c-Jun- and JunD-dependent transcription
por: Larocque, Émilie, et al.
Publicado: (2011)

Transfection of the mutant MYH9 cDNA reproduces the most typical cellular phenotype of MYH9-related disease in different cell lines
por: Panza, Emanuele, et al.
Publicado: (2008)

Cinobufotalin powerfully reversed EBV-miR-BART22-induced cisplatin resistance via stimulating MAP2K4 to antagonize non-muscle myosin heavy chain IIA/glycogen synthase 3β/β-catenin signaling pathway
por: Liu, Yiyi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_es07rp1uk45n3m2ialdv7d044v